Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Tobacco and Cigarette Stocks to Invest In

In this article, we will take a look at some of the best tobacco and cigarette stocks, including companies operating in the e-cigarette and cannabis segments. On March 13, the U.S. Food and Drug Administration (FDA) took a small but important step toward licensing another vape brand, Glas, but only for its tobacco-flavored products. The FDA remains cautious despite new guidelines and is under pressure to speed up approvals that can take up to five years.

Currently, there are only 41 vapes on the approved list for sale in the U.S., which include tobacco and menthol flavors. As mentioned earlier, the FDA authorized Glas to sell only tobacco-related products in the U.S. It has also set a lower evidentiary bar for flavors such as coffee and spices, while maintaining stricter standards for fruit and candy vapes due to their greater appeal to youth. According to Mitch Zeller, a former director of the FDA’s Center for Tobacco Products, more flavor approvals could help adult smokers switch to vapes while reducing e-cigarette competition.

President of the Campaign for Tobacco-Free Kids, Yolanda Richardson, warned that broader flavored product access could attract young users, creating new nicotine addicts. How such a situation will impact the industry and people’s health remains uncertain, as the regulator faces conflicting pressures on both fronts.

With that background, let’s explore our 10 Best Tobacco and Cigarette Stocks to Invest In.

Our Methodology

To identify relevant stocks for this article, we screened for U.S.-listed tobacco and cigarette companies with market capitalizations above $200 million. We also included names from the e-cigarette and cannabis segments. We only shortlisted stocks with at least 15% upside potential, according to consensus, as of the April 15 close. Finally, we selected 10 stocks with the highest upside and ranked them in ascending order.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

10. Tilray Brands Inc. (NASDAQ:TLRY)

Tilray Brands Inc. (NASDAQ:TLRY) is one of the 10 best tobacco and cigarette stocks to invest in.

There are obvious reasons to be optimistic about this medicinal cannabis play. On April 2, Bill Kirk from Roth Capital upgraded Tilray Brands Inc. (NASDAQ:TLRY) from Neutral to Buy while maintaining a price target of $10. The reasons put forward by the analyst for the upgrade included the stability of the company’s Canadian business, a turnaround in its international operations, and an improvement in the beverages segment.

The analyst also noted that the stock price of Tilray is back at levels last recorded in July 2025. The company’s fundamentals have turned positive, and chances of regulatory change have increased, according to the analyst.

On April 2, Alliance Global reduced the price target on Tilray Brands Inc. (NASDAQ:TLRY) from $9 to $7 while maintaining a Neutral rating on the shares. The firm reflected on Tilray’s third-quarter sales miss. Despite that, the stock offers attractive exposure to an expanding medicinal cannabis market. The company benefited from its cost-saving initiatives, resulting in EBITDA exceeding expectations. According to Alliance Global, uncertainty about the ban on hemp was the rationale for the price target reduction.

Tilray Brands Inc. (NASDAQ:TLRY) is involved in growing, researching, and selling medicinal cannabis products. Alongside this, it markets and resells wellness and pharmaceutical products, beverages, and food products made of hemp. Additionally, it also provides goods for entertainment. Its products are sold through several channels, including pharmacies, retailers, and wholesalers.

9. British American Tobacco PLC (NYSE:BTI)

British American Tobacco PLC (NYSE:BTI) is one of the 10 best tobacco and cigarette stocks to invest in.

On April 13, Goldman Sachs analyst Bonnie Herzog reported a price hike of around 3% by Altria Group Inc. (NYSE:MO) on its Marlboro product line in the United States. Herzog expects British American Tobacco plc (NYSE:BTI) to follow suit by hiking prices on its R.J. Reynolds products. The analyst noted that the industry is seeing continued strength in net price realization, driven by manufacturers’ strong pricing power.

On March 26, British American Tobacco PLC (NYSE:BTI) was awarded the Digital Transformation Award during the Verdantix Transform Summit. This reflects the company’s efforts to leverage advanced digital technologies aimed at sustainability and climate progress, making it a standout tobacco name for investors to consider.

The key factor that helped the company stand out is its Digital Sustainability Control Tower. This is a platform that enables data-driven reporting by the company across major sustainability metrics. Additionally, the platform also helps the company to automate Scope 3 data for greater accuracy and efficiency. Jonathan Upward, Group Head of Sustainability, stated:

“This achievement is testament to the strong collaboration across BAT and our strategic partners, and it highlights our continued commitment to building the digital capabilities that underpin our sustainability ambitions and support long term value creation.”

British American Tobacco PLC (NYSE:BTI) is the worldwide seller of nicotine and tobacco products. Its product portfolio includes vapor products, heated products, modern and traditional oral products, and fine-cut and roll-your-own tobacco products. Its products are sold under various brands, including Velo, Dunhill, Pall Mall, and more.

8. Philip Morris International Inc. (NYSE:PM)

Philip Morris International Inc. (NYSE:PM) is one of the 10 best tobacco and cigarette stocks to invest in.

As a household name, there are several recent commercial developments that could entice investors who are looking for quality tobacco stocks. On April 13, Philip Morris International Inc. (NYSE:PM) stated that it will serve as Ferrari Hypersail’s Principal Partner. According to the Group CEO Jacek Olczak, Ferrari’s aggressive goal of setting records at sea perfectly embodies the changes the organization has undergone over time. This collaboration is driven by the futuristic idea that old issues can be solved using modern technological advancements when complemented by human creativity.

Olczak also claims that this achievement is far from being a standard company statement. Rather, it is the continuation of a long-standing relationship that started more than five decades ago. In the long run, this collaboration marks a new direction full of great ambitions and challenges, and driven by the strong belief in the importance of progress.

Earlier on April 10, Matthew Smith from Stifel reduced the price target on Philip Morris International Inc. (NYSE:PM) from $200 to $195 while maintaining a Buy rating on the shares. Smith maintains a positive outlook for tobacco stocks ahead of first-quarter earnings. The analyst sees attractive upside, supported by smoke-free volume growth, a resilient cigarette business, and accelerating earnings growth through 2026.

Philip Morris International Inc. (NYSE:PM) operates as a global tobacco company. Apart from cigarettes, its product portfolio also includes various smoke-free products, wellness products, and consumer accessories. These are being sold under different brands such as ZYN, IQOS, and VEEV.

7. Canopy Growth Corp. (NASDAQ:CGC)

Canopy Growth Corp. (NASDAQ:CGC) is one of the 10 best tobacco and cigarette stocks to invest in.

With the cannabis market attracting significant investor interest, Canopy Growth Corp. (NASDAQ:CGC) could be an attractive opportunity. On March 31, the company introduced Deelish, which is a cannabis line catering to the value segment. The CEO, Luc Mongeau, described the value category as one of the most active categories in the Canadian cannabis industry. Mongeau believes that people are aware of what they need, and this product caters to their needs by offering a very potent marijuana product at a value price level consistent with their purchases.

What also makes Canopy Growth Corp. (NASDAQ:CGC) a highly captivating cannabis player is its inorganic growth strategy. Back on March 16, it reported the successful acquisition of all outstanding shares of MTL Cannabis Corp. (CSE: MTLC). This strategic acquisition is primarily motivated by the goal of forming Canada’s leading medical cannabis platform, while boosting the supply of premium flower into regulated international markets such as Europe.

At the same time, management believes that acquiring a highly profitable entity will enable the company to meet its strategic goal of generating positive adjusted EBITDA for the entire fiscal year of 2027. Additionally, this acquisition also enhances the overall capabilities of the business. Luc Mongeau stressed that this marked another step towards profitability and better operations.

Canopy Growth Corp. (NASDAQ:CGC) manufactures and distributes cannabis, hemp, and items associated with cannabis. The company sells a number of products, which include dried flower and pre-rolled joints, extracts and concentrates, and cannabis edibles. It sells its products under different brands like Storz & Bickel, Tweed, 7ACRES, and more.

6. Turning Point Brands Inc. (NYSE:TPB)

Turning Point Brands Inc. (NYSE:TPB) is one of the 10 best tobacco and cigarette stocks to invest in.

On April 9, Turning Point Brands Inc. (NYSE:TPB) entered into a long-term agreement with TKO Group Holdings Inc. (NYSE:TKO). This partnership seamlessly connects adult nicotine users to tailored integrations and targeted experiences across six distinct TKO-affiliated properties. This deal has also made TPB the official Nicotine Pouch Partner for UFC, Zuffa Boxing, PBR, UFC BJJ, Formula Drift, and the IMG-owned World’s Strongest Man.

At the same time, these diverse assets successfully provide an unmatched direct reach into some of the most intensely involved and fervent adult fan audiences in the broader sports industry.

On April 1, the United States Food and Drug Administration’s strategy to expedite the approval process for nicotine pouches encountered an obstacle. The FDA’s pilot program is aimed at speeding up evaluations for tobacco products offered by several companies, including Turning Point Brands Inc. (NYSE:TPB).

Concerns have been raised over the science behind this decision and the potential risk of developing new nicotine consumers, especially among teenagers. The FDA initiated this experiment amid pressure to streamline its review process, but is allegedly still unsure whether they have enough information to consider both the benefits to adult smokers and the risks posed to adolescents.

Turning Point Brands Inc. (NYSE:TPB) produces and sells branded consumer products. Its product portfolio includes rolling papers, finished cigars, loose-leaf chewing tobacco, and more. Alongside tobacco products, it is also involved in the marketing and sales of cannabis accessories. It operates through several channels, which include wholesalers, retailers, and drug stores, to name a few.

While we acknowledge the potential of TPB to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TPB and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Best Tobacco and Cigarette Stocks to Invest In.

Disclosure: None. Follow Insider Monkey on Google News.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.